Drug information for FIRMAGON
Form
Dosage
Status
Therapeutic Equivalence
Active Ingred
Ref.
Sponsor
Document
POWDER; SUBCUTANEOUS
EQ 120MG BASE/VIAL
Prescription
(Reference Drug)
DEGARELIX ACETATE
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
FERRING
22201
2009-02-17 Review
2009-02-17 Summary Review
2008-12-30 Letter
2008-12-29 Label
POWDER; SUBCUTANEOUS
EQ 80MG BASE/VIAL
Prescription
DEGARELIX ACETATE
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
FERRING
"
Drug Adverse Effects information for FIRMAGON
Role code
Indications
Reaction
# Reports
PS
PRODUCT USED FOR UNKNOWN INDICATION
ABDOMINAL PAIN
1
PS
PRODUCT USED FOR UNKNOWN INDICATION
DISEASE PROGRESSION
1
PS
PRODUCT USED FOR UNKNOWN INDICATION
DRUG INEFFECTIVE
1
PS
PRODUCT USED FOR UNKNOWN INDICATION
HEADACHE
1
PS
PRODUCT USED FOR UNKNOWN INDICATION
HYPERTENSION
1
PS
PRODUCT USED FOR UNKNOWN INDICATION
INJECTION SITE PAIN
1
PS
PRODUCT USED FOR UNKNOWN INDICATION
MYALGIA
1
PS
PRODUCT USED FOR UNKNOWN INDICATION
OEDEMA PERIPHERAL
1
PS
PRODUCT USED FOR UNKNOWN INDICATION
OVERDOSE
1
PS
PRODUCT USED FOR UNKNOWN INDICATION
PYREXIA
1
PS
PRODUCT USED FOR UNKNOWN INDICATION
TONGUE DISORDER
1
PS
PRODUCT USED FOR UNKNOWN INDICATION
TRANSURETHRAL PROSTATECTOMY
2
PS
PRODUCT USED FOR UNKNOWN INDICATION
UNEVALUABLE EVENT
1
PS
PROSTATE CANCER
ABDOMINAL PAIN
2
PS
PROSTATE CANCER
ASTHENIA
2
PS
PROSTATE CANCER
BACK PAIN
2
PS
PROSTATE CANCER
BREAST PAIN
1
PS
PROSTATE CANCER
BREAST SWELLING
1
PS
PROSTATE CANCER
CARDIAC DEATH
1
PS
PROSTATE CANCER
CARDIAC DISORDER
1
PS
PROSTATE CANCER
CONFUSIONAL STATE
2
PS
PROSTATE CANCER
DEATH
2
PS
PROSTATE CANCER
DEPRESSION
2
PS
PROSTATE CANCER
DIARRHOEA
2
PS
PROSTATE CANCER
DIZZINESS
2
PS
PROSTATE CANCER
DYSPNOEA EXERTIONAL
1
PS
PROSTATE CANCER
EATING DISORDER
1
PS
PROSTATE CANCER
FATIGUE
5
PS
PROSTATE CANCER
FLUSHING
1
PS
PROSTATE CANCER
HAEMATOCRIT DECREASED
1
PS
PROSTATE CANCER
HAEMOGLOBIN DECREASED
1
PS
PROSTATE CANCER
HEADACHE
2
PS
PROSTATE CANCER
HOT FLUSH
2
PS
PROSTATE CANCER
HYPOAESTHESIA
1
PS
PROSTATE CANCER
HYPOTENSION
1
PS
PROSTATE CANCER
INJECTION SITE DISCOLOURATION
1
PS
PROSTATE CANCER
INJECTION SITE ERYTHEMA
3
PS
PROSTATE CANCER
INJECTION SITE NODULE
3
PS
PROSTATE CANCER
INJECTION SITE PAIN
2
PS
PROSTATE CANCER
INTERSTITIAL LUNG DISEASE
1
PS
PROSTATE CANCER
METASTASES TO BONE
1
PS
PROSTATE CANCER
MICTURITION URGENCY
1
PS
PROSTATE CANCER
NAUSEA
1
PS
PROSTATE CANCER
NOCTURIA
1
PS
PROSTATE CANCER
PALPITATIONS
1
PS
PROSTATE CANCER
PARAESTHESIA
1
PS
PROSTATE CANCER
PNEUMONIA
1
PS
PROSTATE CANCER
POLLAKIURIA
2
PS
PROSTATE CANCER
QUALITY OF LIFE DECREASED
2
PS
PROSTATE CANCER
RENAL FAILURE
1
PS
PROSTATE CANCER
TESTICULAR ATROPHY
2
PS
PROSTATE CANCER METASTATIC
INTERSTITIAL LUNG DISEASE
1
C
PRODUCT USED FOR UNKNOWN INDICATION
ACUTE MYELOID LEUKAEMIA
6
C
PRODUCT USED FOR UNKNOWN INDICATION
MYELODYSPLASTIC SYNDROME
6
C
PRODUCT USED FOR UNKNOWN INDICATION
PANCYTOPENIA
6
C
PRODUCT USED FOR UNKNOWN INDICATION
PULMONARY EMBOLISM
6
C
PRODUCT USED FOR UNKNOWN INDICATION
THROMBOCYTOPENIA
6
C
PROPHYLAXIS
ACUTE MYELOID LEUKAEMIA
2
C
PROPHYLAXIS
MYELODYSPLASTIC SYNDROME
2
C
PROPHYLAXIS
PANCYTOPENIA
2
C
PROPHYLAXIS
PULMONARY EMBOLISM
2
C
PROPHYLAXIS
THROMBOCYTOPENIA
2
C
PROSTATE CANCER METASTATIC
ACUTE MYELOID LEUKAEMIA
4
C
PROSTATE CANCER METASTATIC
LONG QT SYNDROME
1
C
PROSTATE CANCER METASTATIC
MYELODYSPLASTIC SYNDROME
4
C
PROSTATE CANCER METASTATIC
PANCYTOPENIA
4
C
PROSTATE CANCER METASTATIC
PULMONARY EMBOLISM
4
C
PROSTATE CANCER METASTATIC
PULMONARY OEDEMA
1
C
PROSTATE CANCER METASTATIC
THROMBOCYTOPENIA
4
C
PULMONARY EMBOLISM
ACUTE MYELOID LEUKAEMIA
2
C
PULMONARY EMBOLISM
MYELODYSPLASTIC SYNDROME
2
C
PULMONARY EMBOLISM
PANCYTOPENIA
2
C
PULMONARY EMBOLISM
PULMONARY EMBOLISM
2
C
PULMONARY EMBOLISM
THROMBOCYTOPENIA
2
Ads by Google